Trial intelligence / Profile preview

Corifollitropin alfa in hypogonadotropic hypogonadism

NCT01709331Phase 3Completed

Sponsor
Organon & Co.
Start
Feb 2013
Primary completion
Apr 2015
01

Overview

A Phase 3 trial of corifollitropin alfa in hypogonadotropic hypogonadism (HH), sponsored by Organon & Co.. Started Feb 2013; status: completed.

02

Drugs

corifollitropin alfa
03

Conditions

hypogonadotropic hypogonadism (HH)

Beyond the preview

Go deeper on NCT01709331.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01709331.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call